- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07600359
Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Participants will be divided into two groups and a total of 12 sessions will be given for 3 weeks with a frequency of 4 sessions per week and a duration of 25 minutes. Group 1 will be given autogenic inhibition technique of iliopsoas, Piriformis, hamstrings and erector spinae along with core stability exercises and conentional therapy. Group 2 will be given reciprocal inhibition techniques of iliopsoas, Piriformis, hamstrings and erector spinae along with conventional treatment and core stability exercises.
Group 1 Group 2 WEEK 1 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
- Bridiging ⇢5 reps ⇢no hold
- PIR of illiopsoas ⇢5 reps ⇢10 sec hold
- PIR of PIRiformis ⇢5 reps ⇢10 sec hold
- PIR of hamstrings ⇢5 reps ⇢10 sec hold
- PIR of erector spinae ⇢5 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
- drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
- Bridiging ⇢5 reps ⇢no hold
- RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢5 reps ⇢10 sec hold
- RI-MET of erector spinae ⇢5 reps ⇢10 sec hold Group 1 Group 2 WEEK 2 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
- Bridiging ⇢5reps ⇢3 sec hold
- Clam shell exercises ⇢6 reps
- PIR of illiopsoas ⇢7 reps ⇢10 sec hold
- PIR of PIRiformis ⇢7 reps ⇢10 sec hold
- PIR of hamstrings ⇢ 7 reps ⇢10 sec hold
- PIR of erector spinae ⇢7 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
- Bridiging ⇢5reps ⇢3 sec hold
- Clam shell exercises ⇢6 reps
- RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold
- RI-MET of erector spinae ⇢7 reps ⇢10 sec hold
Group 1 Group 2 WEEK 3 4 SESSEIONS/ WEEK
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
- Supine Bridiging ⇢10 reps ⇢ 6 sec hold
- Clam shell exercises ⇢10 reps ⇢6 sec hold
- PIR of illiopsoas ⇢10 reps ⇢10 sec hold
- PIR of PIRiformis ⇢10 reps ⇢10 sec hold
- PIR of hamstrings ⇢10 reps ⇢ 10 sec hold
- PIR of erector spinae ⇢ 10 reps ⇢10 sec hold
- TENS + hot pack ⇢10 mins
- drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
- Supine Bridiging ⇢10 reps ⇢ 6 sec hold
- Clam shell exercises ⇢10 reps ⇢6 sec hold
- RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold
- RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold
- RI-MET of hamstrings ⇢10 reps ⇢ 10 sec hold
- RI-MET of erector spinae ⇢ 10 reps ⇢10 sec hold
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Fajar Sajjad, DPT
- Numero di telefono: 0331-5817637
- Email: fajarsajjad1999@gmail.com
Backup dei contatti dello studio
- Nome: Marwa Asim, MS-OMPT
- Numero di telefono: 03335339457
- Email: marwa@fui.edu.pk
Luoghi di studio
-
-
Punjab Province
-
Islamabad, Punjab Province, Pakistan, 44000
- Reclutamento
- Foundation University College of Physical Therapy
-
Contatto:
- Fajar Sajjad, DPT
- Numero di telefono: 0331-5817637
- Email: fajarsajjad1999@gmail.com
-
Contatto:
- Marwa Asim, MS-OMPT
- Numero di telefono: 03335339457
- Email: marwa@fui.edu.pk
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Patients having low back pain greater than 4 weeks
- Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test.
- Patients not having any other condition that can affect gait
- 25-45 years
- Both males and females
Exclusion Criteria:
- Patients having nonspecific low back
- Patients with lumbosacral fusion
- Patients with any neurological condition
- Patients with history of trauma of spine
- Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis)
- Patients with any hip joint pathology
- Patients using any assistive device
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Autogenic Inhibition Technique
During week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold PIR of illiopsoas ⇢5 reps ⇢10 sec hold PIR of PIRiformis ⇢5 reps ⇢10 sec hold PIR of hamstrings ⇢5 reps ⇢10 sec hold PIR of erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps PIR of illiopsoas ⇢7 reps ⇢10 sec hold PIR of PIRiformis ⇢7 reps ⇢10 sec hold PIR of hamstrings ⇢ 7 reps ⇢10 sec hold PIR of erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold PIR of illiopsoas ⇢10 reps ⇢10 sec hold PIR of PIRiformis ⇢10 reps ⇢10 sec hold PIR of hamstrings ⇢10 reps ⇢ 10 sec |
During week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position Bridiging PIR of illiopsoas,Piriformis, hamstrings,erector spinae During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Bridiging Clam shell exercises PIR of illiopsoas, PIRiformis, hamstrings, erector spinae During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Supine Bridiging, Clam shell exercises, PIR of illiopsoas PIR of Piriformis, hamstrings and erector spinae
|
|
Sperimentale: Reciprocal Inhibition Technique
During week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold RI-MET of hamstrings ⇢5 reps ⇢10 sec hold RI-MET of erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold RI-MET of erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold RI-MET o |
During week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging, Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas, Piriformis, erector spinae ⇢10 reps ⇢10 sec hold
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Functional disability
Lasso di tempo: before treatment after after 3 weeks
|
It will be measured by using Denver SI joint disability questionnaire which 10 questions questionnaire consisting of scoring range from 0-5 in each item answered.
0 means no disability and 5 means maximum disability.
And total score is calculated in the form of percentage.
Higher the percentage greater is the disability.
|
before treatment after after 3 weeks
|
|
Pain intensity
Lasso di tempo: before treatment and after 3 weeks
|
Pain will be measured by NPRS.
A line of 10 centimeters containing numbers from 0 to 10 marked.
The starting point of the scale indicates 0 or no pain whereas the ending point marks the pain as 10 which means the pain is as worse as it could be.
|
before treatment and after 3 weeks
|
|
Gait Speed
Lasso di tempo: Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
Gait speed will be measured by calculating the distance covered in meters divided by the time taken in seconds during walking assessment. Formula: Gait Speed (m/s) = Distance (m) × Time (s) |
Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
|
Cadance
Lasso di tempo: Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
Cadence will be measured as the number of steps taken per minute during walking assessment. Formula: Cadence (steps/min) = Steps Counted × 60 / Time (s) |
Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
|
Cycle time
Lasso di tempo: Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
Cycle time will be calculated as the time required to complete one gait cycle during walking assessment. Formula: Cycle Time (s) = Time (s) × 2 / Steps Counted |
Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
|
Stride Length
Lasso di tempo: Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
Stride length will be determined by multiplying gait speed with cycle time during walking assessment. Formula: Stride Length (m) = Speed (m/s) × Cycle Time (s) |
Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
|
Step Length
Lasso di tempo: Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
Step length will be calculated as half of the stride length obtained during gait assessment. Formula: Step Length (m) = Stride Length / 2 |
Assessed at baseline (before intervention) and after 3 weeks of intervention.
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Fajar Sajjad, DPT, Foundation University Islamabad
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- FUI/FUCP/CTR/10.26/FajarSajad
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Disfunzione dell'articolazione sacroiliaca
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsReclutamentoCarcinoma della prostata | Stadio IVB Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterReclutamentoAdenocarcinoma prostatico | Cancro alla prostata in stadio II AJCC v8 | Fase I Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterReclutamentoCancro ai polmoni | Adenocarcinoma polmonare | Stadio IA2 Cancro polmonare AJCC v8 | Stadio IA3 Cancro polmonare AJCC v8 | Carcinoma Polmonare in Stadio IA1 American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
University of Southern CaliforniaNational Cancer Institute (NCI)ReclutamentoCarcinoma prostatico localizzato | Cancro alla prostata in stadio II AJCC v8 | Cancro alla prostata in stadio III AJCC v8 | Carcinoma prostatico localmente avanzato | Fase I Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterReclutamentoCarcinoma prostatico resistente alla castrazione | Carcinoma prostatico metastatico | Cancro alla prostata in stadio IVA AJCC v8 | Cancro alla prostata in stadio IVB AJCC v8 | Stadio IV Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterRitiratoAdenocarcinoma prostatico | Cancro alla prostata in stadio II AJCC v8 | Cancro alla prostata in stadio IIC AJCC v8 | Cancro alla prostata in stadio IIA AJCC v8 | Cancro alla prostata in stadio IIB AJCC v8 | Fase I Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletatoStadio III Adenocarcinoma della prostata AJCC v7 | Stadio II Adenocarcinoma prostatico AJCC v7 | Fase I Adenocarcinoma della prostata American Joint Committee on Cancer (AJCC) v7Stati Uniti
-
Jonsson Comprehensive Cancer CenterMiraDXAttivo, non reclutanteAdenocarcinoma prostatico | Cancro alla prostata in stadio II AJCC v8 | Cancro alla prostata in stadio IIC AJCC v8 | Cancro alla prostata in stadio IIA AJCC v8 | Cancro alla prostata in stadio IIB AJCC v8 | Fase I Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterTerminatoCarcinoma prostatico resistente alla castrazione | Carcinoma prostatico metastatico | Cancro alla prostata in stadio IVA AJCC v8 | Cancro alla prostata in stadio IVB AJCC v8 | Stadio IV Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterTerminatoCarcinoma prostatico biochimicamente ricorrente | Carcinoma prostatico metastatico | Neoplasia maligna metastatica nell'osso | Cancro alla prostata in stadio IVA AJCC v8 | Cancro alla prostata in stadio IVB AJCC v8 | Stadio IV Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti